Millipore Sigma Vibrant Logo

HFIB1-100K MILLIPLEX® Human Fibrosis Panel 1

The Human Fibrosis Panel 1, using the Luminex xMAP technology, enables simultaneous quantification of 3 fibrosis protein biomarkers in human serum, plasma and tissue/cell culture samples.

MILLIPLEX® Human Fibrosis Panel 1 MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Key Applications: Multiplexing Detection Methods: Luminex xMAP Research Category: Inflammation & Immunology Research Sub-Category: Inflammation & Autoimmune Mechanisms, Inflammation, Infectious Diseases, Cytokines & Cytokine Receptors, Growth Factors & Receptors, Oncology, Obesity, Metabolic Disorders, Autoimmune disease, Cardiovascular Disease
HFIB1-100K
Design And Price Your Kit

Overview

Replacement Information

Key Specifications Table

Analytes AvailableSpecies ReactivityKey ApplicationsDetection Methods
COMP IL-18BPa Uteroglobin HMplexLuminex xMAP
Description
Catalogue NumberHFIB1-100K
Trade Name
  • MILLIPLEX
DescriptionMILLIPLEX® Human Fibrosis Panel 1
OverviewMILLIPLEX® offers the broadest selection of analytes across a wide range of disease states and species. Once the analytes of interest have been identified, you can rely on the quality that we build into each kit to produce results you can trust. In addition to the assay characteristics listed in the protocol, other performance criteria evaluated during the verification process include: cross-reactivity, dilution linearity, kit stability, and sample behavior (e.g. detectability and stability).

Each MILLIPLEX® panel and kit includes:
• Quality controls (QCs) to qualify assay performance
• Comparison of standard (calibrator) and QC lots to a reference lot to ensure lot-to-lot consistency
• Optimized serum matrix to mimic native analyte environment in serum and plasma samples
• Detection antibody cocktails designed to yield consistent analyte profiles within panel

In addition each panel and kit meets stringent manufacturing criteria to ensure batch-to-batch reproducibility. The MILLIPLEX® Human Fibrosis Panel 1 thus enables you to focus on the therapeutic potential of cytokines and the modulation of cytokine expression. Coupled with the Luminex® xMAP® platform in a magnetic bead format, you receive the advantage of ideal speed and sensitivity, allowing quantitative multiplex detection of dozens of analytes simultaneously, which can dramatically improve productivity.
Background InformationFibrosis is a pathological wound healing response that is common to many chronic diseases and injuries. The abnormal wound healing response of fibrosis involves the excessive accumulation of the extracellular matrix components responsible for the formation of scar tissue. Progressive tissue scarring causes alterations to normal organ structure leading to dysfunction and failure. Fibrosis and related diseases are responsible for an increasing burden of morbidity and mortality worldwide. This panel of fibrosis-related biomarkers enables researchers to advance understanding of the complex processes associated with fibrotic diseases, including but not limited to idiopathic pulmonary fibrosis, liver fibrosis, and lung fibrosis.

Our MILLIPLEX® Human Fibrosis Panel 1 is a 3-plex kit to be used for the simultaneous quantification of any or all of the following analytes in serum, plasma and tissue culture samples: IL-18 Binding Protein A (IL-18BPa), Cartilage Oligomeric Matrix Protein (COMP), and Uteroglobin.

MILLIPLEX® panels include:
• Quality controls (QCs) provided to qualify assay performance
• Lot-to-lot consistency by comparison of standard and QC lots to a reference lot
• Detection antibody cocktails for consistent analyte profiles within the panel
References
Product Information
Detection methodLuminex xMAP
ConfigurationDesign your multiplex kit by choosing available analytes within this panel.
Precision, %
  • Intra-assay: <10%
  • Inter-assay: <20%
Panel TypeMAGNETIC Cytokines/Chemokines
Applications
ApplicationThe Human Fibrosis Panel 1, using the Luminex xMAP technology, enables simultaneous quantification of 3 fibrosis protein biomarkers in human serum, plasma and tissue/cell culture samples.
Key Applications
  • Multiplexing
Application Notes• This assay may be run overnight (16-18 hours) at 2-8°C or for 2 hours at room temperature (20-25°C) with agitation on a plate shaker.
• A maximum of 25 μL per well of 1:200 serum or plasma diluted in Assay Buffer should be used for all analytes. Tissue culture supernatants may require dilution in appropriate control medium. Tissue/cell extracts should be prepared in neutral buffers containing reagents and conditions that do not interfere with assay performance.
Assay Requirements
Researchers will need access to a Luminex® 200™, MAGPIX®, or FLEXMAP 3D® instrument.
Biological Information
Species Reactivity
  • Human
Analytes Available
  • COMP
  • IL-18BPa
  • Uteroglobin
Cross ReactivityNegligible or no cross-reactivity was observed between the antibodies for any one analyte and any of the other analytes in this panel.
Accuracy
  • 95% - 96%
Physicochemical Information
Sensitivity
  • Refer to kit protocol for sensitivities for individual analytes.
Standard Curve Range
  • IL-18BPa: 2-10,000 pg/mL
  • COMP: 10-40,000 pg/mL
  • Uteroglobin: 6-25,000 pg/mL
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsRecommended storage for kit components is 2 - 8°C.
Packaging Information
Material Size96-well plate
Material Package96-well plate
Transport Information
Supplemental Information
Specifications